Skin

Guidelines (7)

Cobimetinib in Combination with Vemurafenib for Treating Unresectable or Metastatic BRAF V600 Mutation-Positive Melanoma (TA414)

26 October 2016

Talimogene Laherparepvec for Treating Unresectable Metastatic Melanoma (TA410)

28 September 2016

Nivolumab in Combination with Ipilimumab for Treating Advanced Melanoma (TA400)

27 July 2016

Trametinib in Combination with Dabrafenib for Treating Unresectable or Metastatic Melanoma (TA396)

22 June 2016

Nivolumab for Treating Advanced (Unresectable or Metastatic) Melanoma (TA384)

18 February 2016

Pembrolizumab for Advanced Melanoma not Previously Treated with Ipilimumab (TA366)

25 November 2015

Pembrolizumab for Treating Advanced Melanoma After Disease Progression with Ipilimumab (TA357)

8 October 2015

Drug Sections (1)

Skin in the News

Treating lentigo maligna with imiquimod

Treating lentigo maligna with imiquimod

28 April 2016

The gold standard of treatment for lentigo maligna...

New treatments for BRAF V600 positive melanoma

28 April 2016

Trametinib (Mekinist) and cobimetinib (Cotellic) are...

New class of immunotherapy for patients with melanoma

New class of immunotherapy for patients with melanoma

28 April 2016

Patients with advanced melanoma can now benefit from...

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.